Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy of Pudendal Nerve Block With Articaine and Triamcinolone in Patients With Pudendal Neuropathy: A Prospective Randomized Placebo-Controlled Trial With Blinded Outcome Assessment

NCT07828574 is registered in ClinicalTrials.gov with Irkutsk State Medical University as lead sponsor.

NCT NCT07828574
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07828574 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy of Pudendal Nerve Block With Articaine and Triamcinolone in Patients With Pudendal Neuropathy: A Prospective Randomized Placebo-Controlled Trial With Blinded Outcome Assessment
Lead sponsor
Irkutsk State Medical University
Phase
Not applicable
Overall status
Active, not recruiting
Start date
January 15, 2025
Completion date
November 10, 2026
Enrollment
120 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pudendal neuralgia pudendal nerve entrapment chronic pelvic pain